<DOC>
	<DOCNO>NCT02936297</DOCNO>
	<brief_summary>Non-celiac gluten sensitivity ( NCGS ) emerge clinical entity define presence intestinal and/or extraintestinal symptom induce ingestion gluten relieve gluten free diet ( GFD ) patient without celiac disease wheat allergy . The pathologic mechanism disorder unknown , know biomarkers associate histopathologic finding . In prospective , randomize control trail , investigate utility patient report symptom questionnaire , well stool gluten urine quantification tool patient NCGS healthy control .</brief_summary>
	<brief_title>Gluten Ingestion Biomarkers Patients w Gluten Sensitivity Healthy Controls Peptides Patients With Non-celiac Gluten Sensitivity Healthy Patients : A Placebo-controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<criteria>Inclusion criterion include Patients &gt; 18 year age Patients willing maintain gluten free diet 6 week Exclusion Criteria ( NCGS ) : Patients &lt; 18 year age Patients positive serology suggestive celiac disease and/or biopsyproven celiac disease and/or Human leukocyte antigen ( HLA ) DQ2 DQ8 positivity . Patients diagnosis inflammatory bowel disease Patients diagnosis acute gastroenteritis Patients pregnant Type 1 Diabetes Mellitus Exclusion criterion ( healthy control ) : NCGS Celiac disease Inflammatory bowel disease Irritable bowel syndrome Acute gastroenteritis Patients pregnant Type 1 Diabetes Mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>